K2 Principal Fund’s Inspire Medical Systems INSP Stock Holding History

K2 Principal Fund’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-14,956	Closed	-$3.78M	–	289
2022 Q4	$3.77M	Buy	+14,956	New	+$3.19M	0.57%	43
2022 Q3	–	Sell	-41,475	Closed	-$8.33M	–	316
2022 Q2	$7.58M	Buy	41,475 +10,596	+34%	+$2.11M	0.84%	37
2022 Q1	$7.93M	Buy	+30,879	New	+$7.06M	0.68%	36

Other funds holding INSP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

K2 Principal Fund's INSP Position: Q1 2023 in Review

K2 Principal Fund sold out of Inspire Medical Systems (INSP) in Q1 2023, closing a stake of 14,956 shares — an estimated $3.78M sold.

K2 Principal Fund first reported a position in INSP in Q1 2022 and held it in 3 quarters. The position peaked at $7.93M in Q1 2022. 373 funds tracked by Wall St. Rank hold INSP as of Q1 2023.

K2 Principal Fund reported no remaining Inspire Medical Systems position as of Q1 2023 after selling out during the quarter.
K2 Principal Fund sold 14,956 Inspire Medical Systems shares in Q1 2023, an estimated $3.78M.
K2 Principal Fund first reported a position in Inspire Medical Systems in Q1 2022 and held it in 3 quarters.
K2 Principal Fund's Inspire Medical Systems position peaked at $7.93M in Q1 2022.
373 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2023.

Based on K2 Principal Fund's 13F filing for Q1 2023, filed 11 May 2023.